Voyager Acquisition (VACH)
Nasdaq Market Closed
Voyager Acquisition Corp. is a blank check company listed with the purpose of completing a business combination with one or more operating businesses. Its Class A ordinary shares represent ownership in a SPAC rather than in a company with an established operating history, product line, or recurring commercial revenue. The company’s main activity is the search for a suitable acquisition or merger target that can become a publicly traded business through the SPAC structure.
As with other special purpose acquisition companies, Voyager Acquisition Corp. is designed to provide a path for a private company to access public markets. Capital raised from investors is typically placed in a trust account while the sponsor and management team review potential targets, conduct due diligence, and negotiate transaction terms. Shareholders generally focus on the team behind the vehicle, the timeframe for completing a deal, the economics of the sponsor promote, and the redemption terms that may apply before a transaction closes.
The investment case for VACH can change quickly if the company announces a proposed combination. At that stage, the market begins to evaluate the target’s industry position, revenue model, financial outlook, valuation, and post-merger governance. Until then, the stock’s characteristics are different from those of an operating company: it is primarily a vehicle for deal execution and capital allocation.
Voyager Acquisition Corp. therefore appeals to investors who follow SPAC opportunities and are willing to assess acquisition risk, transaction uncertainty, and the possibility that no attractive deal is completed. Its long-term identity depends on the business it ultimately combines with, if a transaction is successfully executed.
Last updated
- Market Cap
- 308.66M
- P/E
- 40.2
- P/FCF
- —
- P/S
- —
- Enterprise Value
- 308.63M
- Sector
- Health Care
- Industry
- Biological Products, Except Diagnostic Substances
- Address
- C/O WINSTON & STRAWN LLP, HOUSTON, TX, 77002
VERAXA Biotech Strengthens Financial Position with $27.5 Million Principal Amount Senior Secured Note Financing and $50 Million Share Purchase Agreement
VERAXA Biotech and Secarna Pharmaceuticals Initiate Antibody Oligonucleotide Conjugate Alliance in Immunology
VERAXA Biotech to Attend Key Industry Conferences to Showcase BiTAC Technology Platform
VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- 308.66M
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- 308.63M
- P/E
P/E ratio compares a company's share price to its earnings per share.
- 40.2
- P/B
P/B ratio compares a company's share price to its book value per share.
- -20.12
- P/S
P/S ratio compares a company's share price to its revenue per share.
- —
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- -83.12
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- —
- EPS
- 0.24
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 0%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- —
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- —
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- —
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- -50.06%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- 2.82%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 0
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 0
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 0
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 0
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- 12.53K
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 9.76
Income Statement
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -2.19M | -873.51K | -405.81K | -240.94K | -265.01K |
| EBITDA | -2.19M | -873.51K | -405.81K | -240.94K | -265.01K |
| Net income | 137.09K | 3.16M | 1.89M | 2.49M | 1.95M |
| Basic EPS | 0.01 | 0.05 | 0.07 | 0.08 | 0.01 |
| Diluted EPS | 0.01 | 0.05 | 0.07 | 0.08 | 0.01 |
Balance Sheet
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Total assets | 272.28M | 270.06M | 267.55M | 264.82M | 262.29M |
| Total liabilities | 286.73M | 13.34M | 12.54M | 12.17M | 12.13M |
| Total equity | -15.34M | -13.15M | -12.27M | 252.65M | -11.63M |
| Cash & equivalents | 32.79K | 182.1K | 252.35K | 92.49K | 445.49K |
| Current assets | 44.33K | 193.64K | 263.89K | 104.03K | 457.03K |
| Current liabilities | 274.68M | 1.29M | 491.32K | 125.85K | 86.17K |
Cash Flow
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Operating cash flow | -149.31K | -70.25K | -5.26M | 5.07M | -2.21M |
| Investing cash flow | — | — | — | -5.42M | — |
| Financing cash flow | — | — | — | — | — |
| Change in cash | -149.31K | -70.25K | 159.86K | -353K | -2.21M |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | 8-K — Voyager Acquisition Corp./Cayman Islands | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 10-Q — Voyager Acquisition Corp./Cayman Islands | View Filing | |
| edgar index | SCHEDULE 13G/A — Voyager Acquisition Corp./Cayman Islands | View Filing | |
| edgar index | SCHEDULE 13G/A — Voyager Acquisition Corp./Cayman Islands | View Filing | |
| edgar index | NT 10-Q — Voyager Acquisition Corp./Cayman Islands | View Filing | |
| edgar index | SCHEDULE 13G/A — Voyager Acquisition Corp./Cayman Islands | View Filing | |
| edgar index | SCHEDULE 13G/A — Voyager Acquisition Corp./Cayman Islands | View Filing | |
| edgar index | SCHEDULE 13G/A — Voyager Acquisition Corp./Cayman Islands | View Filing | |
| edgar index | 10-K/A — Voyager Acquisition Corp./Cayman Islands | View Filing | |
| edgar index | 8-K — Voyager Acquisition Corp./Cayman Islands | View Filing | |
| edgar index | 425 — Voyager Acquisition Corp./Cayman Islands | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 425 — Voyager Acquisition Corp./Cayman Islands | View Filing | |
| edgar index | 10-K — Voyager Acquisition Corp./Cayman Islands | View Filing | |
| ten k section | 10-K — business | View Filing | |
| ten k section | 10-K — mda | View Filing | |
| ten k section | 10-K — risk_factors | View Filing | |
| edgar index | 8-K — Voyager Acquisition Corp./Cayman Islands | View Filing | |
| edgar index | 425 — Voyager Acquisition Corp./Cayman Islands | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 424B3 — Voyager Acquisition Corp./Cayman Islands | View Filing | |
| edgar index | SCHEDULE 13G/A — Voyager Acquisition Corp./Cayman Islands | View Filing | |
| edgar index | EFFECT — Voyager Acquisition Corp./Cayman Islands | View Filing | |
| edgar index | SCHEDULE 13G/A — Voyager Acquisition Corp./Cayman Islands | View Filing | |
| edgar index | F-4/A — Voyager Acquisition Corp./Cayman Islands | View Filing | |
| edgar index | CORRESP — Voyager Acquisition Corp./Cayman Islands | View Filing | |
| edgar index | UPLOAD — Voyager Acquisition Corp./Cayman Islands | View Filing | |
| edgar index | SCHEDULE 13G — Voyager Acquisition Corp./Cayman Islands | View Filing | |
| edgar index | 8-K — Voyager Acquisition Corp./Cayman Islands | View Filing | |
| edgar index | 425 — Voyager Acquisition Corp./Cayman Islands | View Filing | |
| edgar index | F-4/A — Voyager Acquisition Corp./Cayman Islands | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | F-4/A — Voyager Acquisition Corp./Cayman Islands | View Filing | |
| edgar index | UPLOAD — Voyager Acquisition Corp./Cayman Islands | View Filing | |
| edgar index | 10-Q — Voyager Acquisition Corp./Cayman Islands | View Filing | |
| edgar index | 8-K — Voyager Acquisition Corp./Cayman Islands | View Filing | |
| edgar index | 425 — Voyager Acquisition Corp./Cayman Islands | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 425 — Voyager Acquisition Corp./Cayman Islands | View Filing | |
| edgar index | F-4/A — Voyager Acquisition Corp./Cayman Islands | View Filing | |
| edgar index | 8-K — Voyager Acquisition Corp./Cayman Islands | View Filing | |
| edgar index | 425 — Voyager Acquisition Corp./Cayman Islands | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | UPLOAD — Voyager Acquisition Corp./Cayman Islands | View Filing | |
| edgar index | SCHEDULE 13G/A — Voyager Acquisition Corp./Cayman Islands | View Filing | |
| edgar index | 10-Q — Voyager Acquisition Corp./Cayman Islands | View Filing | |
| edgar index | SCHEDULE 13G/A — Voyager Acquisition Corp./Cayman Islands | View Filing | |
| edgar index | RW — Voyager Acquisition Corp./Cayman Islands | View Filing | |
| edgar index | F-4 — Voyager Acquisition Corp./Cayman Islands | View Filing | |
| edgar index | F-4/A — Voyager Acquisition Corp./Cayman Islands | View Filing | |
| edgar index | F-4 — Voyager Acquisition Corp./Cayman Islands | View Filing | |
| edgar index | 425 — Voyager Acquisition Corp./Cayman Islands | View Filing | |
| edgar index | 8-K — Voyager Acquisition Corp./Cayman Islands | View Filing | |
| edgar index | 425 — Voyager Acquisition Corp./Cayman Islands | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | SCHEDULE 13G/A — Voyager Acquisition Corp./Cayman Islands | View Filing | |
| edgar index | 425 — Voyager Acquisition Corp./Cayman Islands | View Filing | |
| edgar index | SCHEDULE 13G/A — Voyager Acquisition Corp./Cayman Islands | View Filing | |
| edgar index | 10-Q — Voyager Acquisition Corp./Cayman Islands | View Filing | |
| edgar index | SCHEDULE 13G/A — Voyager Acquisition Corp./Cayman Islands | View Filing | |
| edgar index | 425 — Voyager Acquisition Corp./Cayman Islands | View Filing | |
| edgar index | SCHEDULE 13G — Voyager Acquisition Corp./Cayman Islands | View Filing | |
| edgar index | 8-K — Voyager Acquisition Corp./Cayman Islands | View Filing | |
| edgar index | 425 — Voyager Acquisition Corp./Cayman Islands | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 10-K — Voyager Acquisition Corp./Cayman Islands | View Filing | |
| ten k section | 10-K — business | View Filing | |
| ten k section | 10-K — business | View Filing | |
| ten k section | 10-K — business | View Filing | |
| ten k section | 10-K — risk_factors | View Filing | |
| ten k section | 10-K — risk_factors | View Filing | |
| ten k section | 10-K — risk_factors | View Filing | |
| edgar index | SCHEDULE 13G/A — Voyager Acquisition Corp./Cayman Islands | View Filing | |
| edgar index | SCHEDULE 13G — Voyager Acquisition Corp./Cayman Islands | View Filing |